Xenon Pharmaceuticals (FRA:XP0) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:XP0 Xenon Pharmaceuticals Inc FRA:XP0
25 GF Score
Price €58.50
! 5 Warning Signs
View Full Analysis

What is Xenon Pharmaceuticals FFO per Share?

FFO per Share only applies to REITs.

FRA:XP0
25GF Score
Xenon Pharmaceuticals Inc FRA:XP0
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xenon Pharmaceuticals Business Description

Other Exchanges XENE:USAXP0:Germany
Address 200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
25GF Score

Get the complete analysis for FRA:XP0

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€58.50
Price